Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By boosting these receptors, https://rapheceutique.com/index.php/hair-growth-tablets/